Sustained monomorphic VT (structural heart disease)
Bedside summary
Sustained monomorphic ventricular tachycardia (SMVT — a uniform, wide-complex tachycardia lasting ≥ 30 s or needing intervention) in a patient with STRUCTURAL heart disease is usually SCAR-RELATED re-entry, most often around a prior myocardial-infarct scar (also dilated/hypertrophic cardiomyopathy, ARVC, sarcoid). It signals both an acute haemodynamic threat and an ongoing risk of sudden death. Any wide-complex tachycardia in a patient with known structural heart disease or prior MI is VT until proven otherwise — do NOT be reassured by tolerated blood pressure.
Red flags
- Haemodynamic instability (shock, ischaemia, heart failure, reduced consciousness) → immediate cardioversion
- Wide-complex tachycardia with known structural heart disease / prior MI — treat as VT
- Electrical storm (≥ 3 sustained episodes in 24 h) or repeated ICD shocks
- Acute ischaemia as the trigger
Assessment
Differential diagnosis
- SVT with aberrancy or bundle-branch block
- Pre-excited (antidromic) tachycardia
- Antiarrhythmic-drug or hyperkalaemia-related wide-complex rhythm
- Polymorphic VT / torsades (a different acute pathway)
- Paced rhythm / pacemaker-mediated tachycardia
Investigations
- 12-lead ECG during tachycardia (capture it) — favouring VT: AV dissociation, capture/fusion beats, very wide QRS, concordance, extreme axis
- Electrolytes (K⁺/Mg²⁺), troponin, and assess for ACUTE ISCHAEMIA as a trigger; drug/QT review
- ECHOCARDIOGRAPHY and, later, cardiac MRI to define the substrate/scar; coronary assessment
- After stabilisation: assessment for an ICD and for catheter ablation (substrate mapping)
Management
- Treat any wide-complex tachycardia in structural heart disease AS VT. If UNSTABLE (shock, ischaemia, heart failure, decreased consciousness) → immediate SYNCHRONISED DC CARDIOVERSION.
- If STABLE, correct electrolytes and consider pharmacological cardioversion/rate-limiting with an antiarrhythmic — AMIODARONE (or lidocaine, especially in ischaemia; procainamide is an alternative) — with expert help, and cardiovert if drugs fail or the patient deteriorates.
- Identify and treat REVERSIBLE triggers — acute ischaemia (revascularise), electrolyte disturbance, decompensated heart failure, pro-arrhythmic drugs.
- For an ICD patient with VT, interrogate the device; for ELECTRICAL STORM (≥ 3 episodes/24 h) use amiodarone + beta-blockade, sedation, and treat ischaemia — see the electrical-storm protocol.
- Refer to cardiology/electrophysiology: SMVT with structural heart disease is a strong indication for an ICD (secondary prevention) and for CATHETER ABLATION of the scar substrate to reduce recurrences; optimise heart-failure therapy.
Drugs & doses
Disposition
Complications & pitfalls
- Degeneration to VF and sudden cardiac death
- Haemodynamic collapse; tachycardia-mediated cardiomyopathy
- Recurrent shocks and psychological impact; electrical storm
Exam pearls
- Wide-complex tachycardia + structural heart disease/old MI = VT until proven otherwise — a tolerated BP does NOT exclude VT.
- Unstable → synchronised DC cardioversion; stable → amiodarone (or lidocaine in ischaemia) with expert help, and cardiovert if it fails.
- Never treat a possible VT as “SVT” with verapamil/AV-nodal blockers — it can precipitate collapse.
- SMVT with structural heart disease usually warrants an ICD and often catheter ablation — refer to EP; always hunt a reversible trigger (ischaemia, electrolytes).
- Recurrent/incessant VT = electrical storm — amiodarone + beta-blocker, sedation, treat ischaemia (separate protocol).
Any wide-complex tachycardia in structural heart disease is VT: if unstable, synchronised DC cardioversion now; if stable, correct electrolytes and give amiodarone (or lidocaine in ischaemia) with expert help, cardioverting if drugs fail. Treat reversible triggers (ischaemia, electrolytes, heart failure, drugs). SMVT with structural disease is a strong indication for an ICD and often catheter ablation — refer to electrophysiology; manage electrical storm on its own pathway.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.